Literature DB >> 29402644

γδ T cell responses: How many ligands will it take till we know?

David Vermijlen1, Deborah Gatti2, Ariadni Kouzeli3, Teja Rus3, Matthias Eberl4.   

Abstract

γδ T cells constitute a sizeable and non-redundant fraction of the total T cell pool in all jawed vertebrates, but in contrast to conventional αβ T cells they are not restricted by classical MHC molecules. Progress in our understanding of the role of γδ T cells in the immune system has been hampered, and is being hampered, by the considerable lack of knowledge regarding the antigens γδ T cells respond to. The past few years have seen a wealth of data regarding the TCR repertoires of distinct γδ T cell populations and a growing list of confirmed and proposed molecules that are recognised by γδ T cells in different species. Yet, the physiological contexts underlying the often restricted TCR usage and the chemical diversity of γδ T cell ligands remain largely unclear, and only few structural studies have confirmed direct ligand recognition by the TCR. We here review the latest progress in the identification and validation of putative γδ T cell ligands and discuss the implications of such findings for γδ T cell responses in health and disease.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Cancer; Immunotherapy; Infection; Innate immunity; Ligand recognition; Stress immune surveillance; T cell receptor; Unconventional T cells

Mesh:

Substances:

Year:  2018        PMID: 29402644     DOI: 10.1016/j.semcdb.2017.10.009

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  35 in total

1.  Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth.

Authors:  Maria Papadopoulou; Tanya Dimova; Muki Shey; Libby Briel; Helen Veldtsman; Nondumiso Khomba; Hadn Africa; Marcia Steyn; Willem A Hanekom; Thomas J Scriba; Elisa Nemes; David Vermijlen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-14       Impact factor: 11.205

Review 2.  Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells.

Authors:  Ling Wu; Qianru Wei; Joanna Brzostek; Nicholas R J Gascoigne
Journal:  Cell Mol Immunol       Date:  2020-05-25       Impact factor: 11.530

Review 3.  Unconventional T cells and kidney disease.

Authors:  Hannah Kaminski; Lionel Couzi; Matthias Eberl
Journal:  Nat Rev Nephrol       Date:  2021-08-26       Impact factor: 28.314

Review 4.  Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy.

Authors:  Xue Yao; Sandro Matosevic
Journal:  BioDrugs       Date:  2021-08-24       Impact factor: 5.807

5.  Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.

Authors:  Chia-Hung Christine Hsiao; Khiem Nguyen; Yiming Jin; Olga Vinogradova; Andrew J Wiemer
Journal:  Cell Chem Biol       Date:  2022-01-25       Impact factor: 9.039

Review 6.  γδ T cells in rheumatic diseases: from fundamental mechanisms to autoimmunity.

Authors:  Cuong Thach Nguyen; Emanual Maverakis; Matthias Eberl; Iannis E Adamopoulos
Journal:  Semin Immunopathol       Date:  2019-09-10       Impact factor: 9.623

7.  Activation of Human Vδ2+ γδ T Cells by Staphylococcus aureus Promotes Enhanced Anti-Staphylococcal Adaptive Immunity.

Authors:  Andrew J R Cooper; Stephen J Lalor; Rachel M McLoughlin
Journal:  J Immunol       Date:  2020-07-10       Impact factor: 5.422

8.  A luciferase lysis assay reveals in vivo malignant cell sensitization by phosphoantigen prodrugs.

Authors:  Jin Li; Nicholas A Lentini; David F Wiemer; Andrew J Wiemer
Journal:  Biochem Pharmacol       Date:  2019-10-16       Impact factor: 5.858

Review 9.  γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Authors:  Bruno Silva-Santos; Sofia Mensurado; Seth B Coffelt
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

10.  Antigen recognition by human γδ T cells: one step closer to knowing.

Authors:  Matthias Eberl
Journal:  Immunol Cell Biol       Date:  2020-04-23       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.